Regulatory consulting assistance for medical device developer. Research and development for clinical studies in the blueprint medtech. Pre-submission assessment & package preparation. Task order 03.…
Active Awarded Last action
- Contract number
- 75N95024F00001
- Awardee
-
PPD Development LP UEI ZANENSW6C665
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $370,621
Award facts
- Opportunity
-
- 75N95024F00001 Solicitation number
- Contract value 100% obligated
- $370,621.00 Current and potential, with all options
- Completion date 51% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Cape Fear, NC 28401, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $181,755 | |
| Exercise an Option | $3,496 | |
| Exercise an Option | $169,638 | |
| Exercise an Option | $1,748 | |
| Exercise an Option | $12,236 | |
| Original award | $1,748 |
About this award
This federal contract award to PPD Development LP, a global contract research organization (CRO), provides regulatory consulting assistance for a medical device developer under the Blueprint MedTech program. The $370,621 cost-plus-fixed-fee contract includes research and development for clinical studies, pre-submission assessment, and package preparation. The award is issued by the National Institute on Drug Abuse, a civilian agency, and is not set aside. PPD Development LP is a subsidiary of Thermo Fisher Scientific and has established itself as a key partner in advancing public health initiatives and medical research programs across multiple federal agencies. The company holds several significant Indefinite Delivery Vehicles (IDVs) with agencies such as the National Institute of Allergy and Infectious Diseases (NIAID) and the National Cancer Institute, positioning it to provide a wide array of clinical trial management, regulatory affairs support, and specialized research and development services.
Description
Regulatory consulting assistance for medical device developer. Research and development for clinical studies in the blueprint medtech. Pre-submission assessment & package preparation. Task order 03. 04/09/2024 - 04/08/2029.
Quick answers
Who was awarded contract 75N95024F00001?
75N95024F00001 was awarded to PPD Development LP by National Institute on Drug Abuse (National Institutes of Health) on April 9, 2024.
How much is contract 75N95024F00001 worth?
The government has obligated $370,621 on 75N95024F00001.
Is contract 75N95024F00001 an order under another contract?
Yes. 75N95024F00001 is a delivery order under 75N95022D00020, an indefinite delivery contract.
Was contract 75N95024F00001 competed?
The extent of competition for 75N95024F00001 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award